Can CAP guideline adherence improve patient outcome in internal medicine departments?

European Respiratory Journal

Volumn 32, Issue 4, 2008, Pages 902-910

  Blasi, F ^a   Iori, I ^c   Bulfoni, A ^d   Corrao, S ^e   Costantino, S ^f   Legnani, D ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c S MARIA NUOVA HOSPITAL   (Italy)

^d SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^e UNIVERSITY OF PALERMO   (Italy)

^f UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Antibiotic; Community acquired pneumonia; Guidelines

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CLARITHROMYCIN; CLINDAMYCIN; LEVOFLOXACIN; METRONIDAZOLE; PENICILLIN G; SULTAMICILLIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMMUNITY ACQUIRED PNEUMONIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG TREATMENT FAILURE; FEMALE; HOSPITAL DEPARTMENT; HUMAN; INTERNAL MEDICINE; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GUIDELINE ADHERENCE; HUMANS; INTENSIVE CARE; INTERNAL MEDICINE; ITALY; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 58849116396     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00092607     Document Type: Article

References (19)

1. Macfarlane JT, Colville A, Guion A, Macfarlane RM, Rose DH. Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet 1993; 341: 511-514.
2. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993; 137: 977-988.
3. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: Suppl. 2, S27-S72.
4. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1138-1180.
5. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
6. Menéndez R, Torres A, Zalacain R, et al. Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med 2005; 172: 757-762.
7. Dean NC, Bateman KA, Donnelly SM, Silver MP, Snow GL, Hale D. Improved clinical outcomes with utilization of community-acquired pneumonia guideline. Chest 2006; 130: 794-799.
8. Rello J, Bodi M, Mariscal D, et al. Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest 2003; 123: 174-180.
9. Ewig S, Ruiz M, Mensa J, et al. Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med 1998; 158: 1102-1108.
10. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987; 136: 225-244.
11. Blasi F, Bulfoni A, Concia E, et al. Gestione delle infezioni delle basse vie respiratorie in medicina interna [Management of lower respiratory tract infections in internal medicine]. Ital J Intern Med 2002; 1: Suppl. 2, 1-69.
12. Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999; 159: 2562-2572.
13. Houck PM, MacLehose RF, Niederman MS, Lowery JK. Empiric antibiotic therapy and mortality among medicare pneumonia inpatients in 10 western states: 1993, 1995, and 1997. Chest 2001; 119: 1420-1426.
14. Arnold FW, Summersgill JT, Lajoie AS, et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med 2007; 175: 1086-1093.
15. Baddour LM, Yu VL, Klugman KP, et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 2004; 170: 440-444.
16. Shefet D, Robenshtock E, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev 2005; 2: CD004418.
17. Fernández-Sabé N, Carratalà J, Roso n B, et al. Communityacquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine 2003; 82: 159-169.
18. Ewig S, Torres A, Woodhead M. Assessment of pneumonia severity: a European perspective. Eur Respir J 2006; 27: 6-8.
19. Marchese A, Ardito F, Fadda G, et al. PROTEKT Italy: third year results and conclusions. G Ital Microbiol Med Odontoiatrica Clin 2005; 9: 69-106.